BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 20144966)

  • 1. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
    Behar DM; Rosset S; Tzur S; Selig S; Yudkovsky G; Bercovici S; Kopp JB; Winkler CA; Nelson GW; Wasser WG; Skorecki K
    Hum Mol Genet; 2010 May; 19(9):1816-27. PubMed ID: 20144966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
    Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
    Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
    Nelson GW; Freedman BI; Bowden DW; Langefeld CD; An P; Hicks PJ; Bostrom MA; Johnson RC; Kopp JB; Winkler CA
    Hum Mol Genet; 2010 May; 19(9):1805-15. PubMed ID: 20124285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
    Freedman BI; Langefeld CD; Lu L; Divers J; Comeau ME; Kopp JB; Winkler CA; Nelson GW; Johnson RC; Palmer ND; Hicks PJ; Bostrom MA; Cooke JN; McDonough CW; Bowden DW
    PLoS Genet; 2011 Jun; 7(6):e1002150. PubMed ID: 21698141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.
    Freedman BI; Hicks PJ; Bostrom MA; Comeau ME; Divers J; Bleyer AJ; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
    Nephrol Dial Transplant; 2009 Nov; 24(11):3366-71. PubMed ID: 19567477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.
    Kopp JB; Smith MW; Nelson GW; Johnson RC; Freedman BI; Bowden DW; Oleksyk T; McKenzie LM; Kajiyama H; Ahuja TS; Berns JS; Briggs W; Cho ME; Dart RA; Kimmel PL; Korbet SM; Michel DM; Mokrzycki MH; Schelling JR; Simon E; Trachtman H; Vlahov D; Winkler CA
    Nat Genet; 2008 Oct; 40(10):1175-84. PubMed ID: 18794856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
    Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI
    Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
    Tzur S; Rosset S; Skorecki K; Wasser WG
    Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease.
    Palmer ND; Ng MC; Hicks PJ; Mudgal P; Langefeld CD; Freedman BI; Bowden DW
    PLoS One; 2014; 9(2):e88273. PubMed ID: 24551085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.
    Freedman BI; Hicks PJ; Bostrom MA; Cunningham ME; Liu Y; Divers J; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
    Kidney Int; 2009 Apr; 75(7):736-45. PubMed ID: 19177153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
    Kao WH; Klag MJ; Meoni LA; Reich D; Berthier-Schaad Y; Li M; Coresh J; Patterson N; Tandon A; Powe NR; Fink NE; Sadler JH; Weir MR; Abboud HE; Adler SG; Divers J; Iyengar SK; Freedman BI; Kimmel PL; Knowler WC; Kohn OF; Kramp K; Leehey DJ; Nicholas SB; Pahl MV; Schelling JR; Sedor JR; Thornley-Brown D; Winkler CA; Smith MW; Parekh RS;
    Nat Genet; 2008 Oct; 40(10):1185-92. PubMed ID: 18794854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.
    Cooke JN; Bostrom MA; Hicks PJ; Ng MC; Hellwege JN; Comeau ME; Divers J; Langefeld CD; Freedman BI; Bowden DW
    Nephrol Dial Transplant; 2012 Apr; 27(4):1505-11. PubMed ID: 21968013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa.
    Oleksyk TK; Nelson GW; An P; Kopp JB; Winkler CA
    PLoS One; 2010 Jul; 5(7):e11474. PubMed ID: 20634883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.
    Bailey JNC; Palmer ND; Ng MCY; Bonomo JA; Hicks PJ; Hester JM; Langefeld CD; Freedman BI; Bowden DW
    Hum Genet; 2014 Jun; 133(6):769-779. PubMed ID: 24385048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
    Genovese G; Friedman DJ; Ross MD; Lecordier L; Uzureau P; Freedman BI; Bowden DW; Langefeld CD; Oleksyk TK; Uscinski Knob AL; Bernhardy AJ; Hicks PJ; Nelson GW; Vanhollebeke B; Winkler CA; Kopp JB; Pays E; Pollak MR
    Science; 2010 Aug; 329(5993):841-5. PubMed ID: 20647424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study.
    Franceschini N; Voruganti VS; Haack K; Almasy L; Laston S; Goring HH; Umans JG; Lee ET; Best LG; Fabsitz RR; MacCluer JW; Howard BV; North KE; Cole SA
    Hum Genet; 2010 Mar; 127(3):295-301. PubMed ID: 19921264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney disease and African ancestry.
    Pollak MR
    Nat Genet; 2008 Oct; 40(10):1145-6. PubMed ID: 18818713
    [No Abstract]   [Full Text] [Related]  

  • 19. The MYH9/APOL1 region and chronic kidney disease in European-Americans.
    O'Seaghdha CM; Parekh RS; Hwang SJ; Li M; Köttgen A; Coresh J; Yang Q; Fox CS; Kao WH
    Hum Mol Genet; 2011 Jun; 20(12):2450-6. PubMed ID: 21429915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies.
    Lewis JP; Palmer ND; Hicks PJ; Sale MM; Langefeld CD; Freedman BI; Divers J; Bowden DW
    Diabetes; 2008 Aug; 57(8):2220-5. PubMed ID: 18443202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.